Interestingly, except for BARX2, MM and primary effusion lymphoma cell lines lacked activity of any NKL-code member, indicating aberrant downregulation of HHEX and NKX6-3. Thus, in mature B-cell malignancies, NKL homeobox genes may perform tumor suppressor activity. Here, BARX2 is linked to Miyoshi myopathy.